Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Close filters
Filter by:
Products from Innaxon

Innaxon is a company based at in Tewkesbury, United Kingdom focussing on innate immunity, TLR agonists and small molecule inhibitors for research on innate immunity.
More information at: innaxon.co.uk
No results were found for the filter!
Item number: IAX-100-003-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.1-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly...
Keywords: | Monophosphoryl Lipid A [MPLA] derived from E. coli R515 (Re) LPS (biosynthetic) |
Application: | TLR4 activator |
From 140.00€ *
Item number: IAX-200-052-M001
Potent sequence of an inhibitory ODN of the poly-G class I targeting TLR9, but without effect on TLR7 and TLR8 signaling, for in vivo use in rodents (50-150 µg per injection). Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
Keywords: | Inhibitory ODN (iODN): Class I |
Application: | TLR9 competitor |
MW: | 6735 D |
From 109.00€ *
Item number: IAX-200-201-C100
Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1826 (Cat. No.: IAX-200-002). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
Application: | Negative Control for ODN 1826 (IAX-200-002) |
MW: | 6383 D |
109.00€ *
Item number: IAX-200-021-M005
Activates TLR3, MDA5/Helicard and RIG-I. Optimal working concentration depends upon target receptor accessibility, number, density, as well as cell type, and therefore needs to be determined for each application. Recommended concentration range: in vitro: 0.5-10 µg/ml, in vivo: 5mg/kg.
Keywords: | Polyinosinic-polycytidylic acid, potassium salt (poly (I:C)) |
Application: | TLR3, MDA5/Helicard, RIG-I activator |
From 125.00€ *
Item number: IAX-200-001-M001
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1720 (Cat. No.: IAX-200-200).
Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
Application: | TLR9 activator |
MW: | 6383 D |
From 140.00€ *
Item number: IAX-200-004-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
Application: | TLR9 activator |
MW: | 6644 D |
From 140.00€ *
![Physiological Saline [Sodium Chloride 0.9%] Endotoxin-free (sterile) Physiological Saline [Sodium Chloride 0.9%] Endotoxin-free (sterile)](/custom/plugins/NetiThemeBiomol/Resources/Themes/Frontend/Biomol/frontend/_public/src/img/no-picture.jpg)
Item number: IAX-900-003-3010
Chemical. Use for the dilution of TLRpureTM LPS and solubilisation of endotoxin-free reagents (e.g. ODNs).
Keywords: | Sodium Chloride 0.9% |
CAS | 7647-14-5 |
From 30.00€ *
Item number: IAX-100-011-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
Keywords: | Lipopolysaccharide (LPS) from Salmonella typhimurium, S-type (smooth/wild-type) LPS |
Application: | TLR4 activator |
From 107.00€ *
Item number: IAX-600-001-M001
Described to interfere with human, rat and mouse TLR4/CD14 signaling, other species not tested. Optimal working concentration depends upon the type, purity and concentration and of TLR4 ligand, carrier protein such as LPS-binding protein (LBP), soluble and membrane-bound CD14, the presence of TLR4 co-receptors (e.g....
Keywords: | Methyl 6-deoxy-6-N-dimethyl-N-cyclopentylammonium-2,3-di-O-tetradecyl-?-D-glucopyranoside iodide |
Application: | CD14/TLR4 Antagonist |
CAS | 1202388-64-4 |
MW: | 810.02 D |
264.00€ *
Item number: IAX-100-009-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
Keywords: | Lipopolysaccharide (LPS) from Salmonella abortus equi, S-type (smooth/wild-type) LPS |
Application: | TLR4 activator |
From 107.00€ *
Item number: IAX-200-002-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1982 (Cat. No.: IAX-200-201).
Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
Application: | TLR9 activator |
Reactivity: | Mouse, Rat |
MW: | 6383 D |
From 140.00€ *
Item number: IAX-200-006-C100
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2137 (Cat. No.: IAX-200-206).
Keywords: | CpG ODN TLR9 Agonist: B Type (species: human and rodent) |
Application: | TLR9 activator |
MW: | 7720 D |
From 140.00€ *